BIG
ADPT icon

Brooklyn Investment Group’s Adaptive Biotechnologies ADPT Stock Holding History

Brooklyn Investment Group’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,006
Closed -$250K – 1834
2025
Q4 		$250K Sell
15,006
-4,928
-25% -$80.4K 0.01% 1202
2025
Q3 		$235K Buy
19,934
+18,725
+1,549% +$228K 0.03% 526
2025
Q2 		$14.1K Sell
1,209
-1,511
-56% -$13.7K ﹤0.01% 1987
2025
Q1 		$20.2K Sell
2,720
-269
-9% -$2.07K ﹤0.01% 1165
2024
Q4 		$17.9K Buy
+2,989
New +$16.5K 0.01% 782

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Brooklyn Investment Group's ADPT Position: Q1 2026 in Review

Brooklyn Investment Group sold out of Adaptive Biotechnologies (ADPT) in Q1 2026, closing a stake of 15,006 shares — an estimated $250K sold.

Brooklyn Investment Group first reported a position in ADPT in Q4 2024 and held it in 5 quarters. The position peaked at $250K in Q4 2025. 298 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Brooklyn Investment Group reported no remaining Adaptive Biotechnologies position as of Q1 2026 after selling out during the quarter.
  • Brooklyn Investment Group sold 15,006 Adaptive Biotechnologies shares in Q1 2026, an estimated $250K.
  • Brooklyn Investment Group first reported a position in Adaptive Biotechnologies in Q4 2024 and held it in 5 quarters.
  • Brooklyn Investment Group's Adaptive Biotechnologies position peaked at $250K in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.